Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis.

Bomze, David; Sprecher, Eli; Geller, Shamir

Bomze, David; Sprecher, Eli; Geller, Shamir.

Afiliación

Bomze D; Division of Dermatology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel.
Sprecher E; Division of Dermatology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel.
Geller S; Division of Dermatology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel.

J Dermatol ; 49(8): 769-774, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35475524

Asunto(s)

COVID-19; Síndrome de Stevens-Johnson; Cicatriz; Femenino; Humanos; Ivermectina/efectos adversos; Masculino; Persona de Mediana Edad; Farmacovigilancia

Palabras clave

FDA adverse event reporting system; Stevens-Johnson syndrome; ivermectin; severe cutaneous adverse event; toxic epidermal necrolysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases / 6_skin_diseases Asunto principal: Síndrome de Stevens-Johnson / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Israel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google